Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks
出版年份 2022 全文链接
标题
Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-06-16
DOI
10.1038/s41598-022-13279-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
- (2021) Tord Hompland et al. Cancers
- The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients
- (2021) Astrid Børretzen et al. Journal of Pathology Clinical Research
- Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
- (2021) Marzieh Ehsani et al. Cancers
- Low Levels of Urinary PSA Better Identify Prostate Cancer Patients
- (2021) Sergio Occhipinti et al. Cancers
- Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
- (2021) Milena Matuszczak et al. Cancers
- miR-TV: an interactive microRNA Target Viewer for microRNA and target gene expression interrogation for human cancer studies
- (2020) Chao-Yu Pan et al. Database-The Journal of Biological Databases and Curation
- The oncogenic role of Jagged1/Notch signaling in cancer
- (2020) Meng-xi Xiu et al. BIOMEDICINE & PHARMACOTHERAPY
- Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
- (2020) Rebecca Smith et al. Scientific Reports
- Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores
- (2019) Brandon A. Mahal et al. EUROPEAN UROLOGY
- Cancer statistics for African Americans, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metastatic castration‐sensitive prostate cancer: Abiraterone, docetaxel, or…
- (2019) Pedro C. Barata et al. CANCER
- miR‑628 reduces prostate cancer proliferation and invasion via the FGFR2 signaling pathway
- (2019) Jun Chen et al. Experimental and Therapeutic Medicine
- MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells
- (2019) Patrice Cagle et al. Scientific Reports
- Cost-effectiveness model of abiraterone plus prednisone, cabazitaxel plus prednisone and enzalutamide for visceral metastatic castration resistant prostate cancer therapy after docetaxel therapy resistance
- (2019) Yazan K. Barqawi et al. JOURNAL OF MEDICAL ECONOMICS
- Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
- (2019) David Bidarra et al. Frontiers in Oncology
- Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases
- (2019) Leslimar Rios-Colon et al. TUMOR BIOLOGY
- The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines
- (2018) HectorR Contreras et al. ASIAN JOURNAL OF ANDROLOGY
- Diagnostic and prognostic value of microRNA-628 for cancers
- (2018) Jing-Hua Li et al. Journal of Cancer
- MicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment
- (2018) Ning Yang et al. Frontiers in Immunology
- On the Dependency of Cellular Protein Levels on mRNA Abundance
- (2016) Yansheng Liu et al. CELL
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
- (2015) Ewa Kopczyńska Wspolczesna Onkologia-Contemporary Oncology
- Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
- (2015) Wendy E. Barrington et al. JAMA Oncology
- Adipocyte Secreted Factors Enhance Aggressiveness of Prostate Carcinoma Cells
- (2015) Ângela Moreira et al. PLoS One
- Circulatory miR-628-5p is downregulated in prostate cancer patients
- (2014) Anvesha Srivastava et al. TUMOR BIOLOGY
- The Notch ligand Jagged1 as a target for anti-tumor therapy
- (2014) Demin Li Frontiers in Oncology
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men
- (2013) I. J. Powell et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database
- (2011) Christopher J. Keto et al. BJU INTERNATIONAL
- SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
- (2011) Berna Uygur et al. Molecular Cancer
- NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
- (2011) C R Jeter et al. ONCOGENE
- Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
- (2009) K. E. Knudsen et al. CLINICAL CANCER RESEARCH
- Global signatures of protein and mRNA expression levels
- (2009) Raquel de Sousa Abreu et al. Molecular BioSystems
- How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes
- (2008) Yanfang Guo et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion
- (2008) J.-H. Choi et al. CANCER RESEARCH
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Differential Effects of Leptin on the Invasive Potential of Androgen-Dependent and -Independent Prostate Carcinoma Cells
- (2008) Dayanand D. Deo et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started